- Randomized trial of adjuvant intraperitoneal alpha-interferon in stage III ovarian cancer patients who have no evidence of disease after primary surgery and chemotherapy: An intergroup study. Alberts, D.S., Hannigan, E.V., Liu, P.Y., Jiang, C., Wilczynski, S., Copeland, L., Markman, M. Gynecol. Oncol. (2006)